From the Tip to the Iceberg Below-Evolving Our Molecular Understanding of Thyroid Nodules.
作者信息
Alexander Erik K
机构信息
Thyroid Section, Department of Medicine, Brigham & Women's Hospital; Harvard Medical School, Boston, MA, USA.
出版信息
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2357-e2358. doi: 10.1210/clinem/dgab087.
Abstract
摘要
相似文献
1
From the Tip to the Iceberg Below-Evolving Our Molecular Understanding of Thyroid Nodules.从尖端到下方的冰山——深化我们对甲状腺结节的分子理解
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2357-e2358. doi: 10.1210/clinem/dgab087.
2
Preoperative Molecular Testing of Thyroid Nodules: Current Concepts.甲状腺结节的术前分子检测：当前概念。
Neuroimaging Clin N Am. 2021 Aug;31(3):301-312. doi: 10.1016/j.nic.2021.04.009.
3
4
What is the role of molecular markers in the management of "indeterminate" thyroid nodules?分子标志物在“不确定”甲状腺结节的管理中起什么作用？
Cancer Cytopathol. 2013 May;121(5):223-4. doi: 10.1002/cncy.21289.
5
The Role of Molecular Testing for the Indeterminate Thyroid FNA.甲状腺细针穿刺抽吸活检结果不确定时的分子检测作用
Genes (Basel). 2019 Sep 23;10(10):736. doi: 10.3390/genes10100736.
6
Utility of molecular testing in the management of thyroid nodules - a clinical perspective.分子检测在甲状腺结节管理中的应用——临床视角
Cytopathology. 2015 Oct;26(5):284-7. doi: 10.1111/cyt.12281.
7
Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.甲状腺细针穿刺活检结果不确定的甲状腺结节中超声特征与Afirma基因表达分类器结果之间的关系
AJR Am J Roentgenol. 2015 Oct;205(4):861-5. doi: 10.2214/AJR.14.13984.
8
Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.超声特征、细胞形态学和突变检测对甲状腺恶性及可疑结节细针穿刺细胞学样本诊断准确性的影响：141例患者的前瞻性分析
Clin Endocrinol (Oxf). 2019 Dec;91(6):851-859. doi: 10.1111/cen.14089. Epub 2019 Oct 1.
9
Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?高阴性预测值的基因表达分类器能否解决不确定的甲状腺细针抽吸困境？
Cancer Cytopathol. 2013 Mar;121(3):116-9. doi: 10.1002/cncy.21277. Epub 2013 Jan 30.
10
Search for genetic mutations in cytological samples from thyroid nodules as a diagnostic tool: reality, hope or myth?将甲状腺结节细胞学样本中的基因突变作为诊断工具的探索：现实、希望还是神话？
J Endocrinol Invest. 2010 Sep;33(8):576-8. doi: 10.1007/BF03346651.
本文引用的文献
1
Plasma Cell-Free DNA to Differentiate Malignant from Benign Thyroid Nodules.浆细胞游离 DNA 区分甲状腺良恶性结节。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2262-e2270. doi: 10.1210/clinem/dgab030.
2
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis.游离循环肿瘤DNA指导的治疗应用于难治性转移性实体癌的前瞻性可行性研究：一项中期分析
JCO Precis Oncol. 2017 Jun 26;1. doi: 10.1200/PO.16.00059. eCollection 2017.
3
Molecular Diagnostic Evaluation of Thyroid Nodules.甲状腺结节的分子诊断评估。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):85-97. doi: 10.1016/j.ecl.2018.10.004. Epub 2018 Dec 10.
4
Integrated genomic characterization of papillary thyroid carcinoma.甲状腺乳头状癌的综合基因组特征分析
Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050.
5
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.术前诊断不确定细胞学的良性甲状腺结节。
N Engl J Med. 2012 Aug 23;367(8):705-15. doi: 10.1056/NEJMoa1203208. Epub 2012 Jun 25.
6
Increasing incidence of thyroid cancer in the United States, 1973-2002.1973年至2002年美国甲状腺癌发病率上升情况。
JAMA. 2006 May 10;295(18):2164-7. doi: 10.1001/jama.295.18.2164.
Zotero 插件